Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata
Author:
Funder
Eli Lilly and Company
Pfizer
Publisher
Elsevier BV
Reference8 articles.
1. Atopic dermatitis: global epidemiology and risk factors;Nutten;Ann Nutr Metab.,2015
2. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis;Alkhalifah;J Am Acad Dermatol.,2010
3. Clinical significance of the coexistence of alopecia areata and atopic dermatitis in Korea;Lee;Ann Dermatol.,2019
4. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials;Guttman-Yassky;Lancet,2021
5. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition;Xing;Nat Med.,2014
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug-Induced Alopecia Areata From Upadacitinib;Cureus;2024-08-11
2. 578 - Cost per responder in Brazil (EASI-75, EASI90 and ΔNRS ≥4) of biologics and JAK inhibitors based on a network-meta-analysis of therapies for atopic dermatitis;British Journal of Dermatology;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3